Drug‐induced resistance and phenotypic switch in triple‐negative breast cancer can be controlled via resolution and targeting of individualized signaling signatures
Swetha Vasudevan, Ibukun A. Adejumobi, Heba Alkhatib, Sangita Roy Chowdhury, Shira Stefansky, Ariel M. Rubinstein, Nataly Kravchenko‐balasha
Research output: Contribution to journal › Article › peer-review
16Scopus
citations
Fingerprint
Dive into the research topics of 'Drug‐induced resistance and phenotypic switch in triple‐negative breast cancer can be controlled via resolution and targeting of individualized signaling signatures'. Together they form a unique fingerprint.